Atlas FDA

VIEWPOINT(TM) CK SYSTEM

FDA premarket approval P010018 · decided 2002-04-11

Approval details

PMA number
P010018
Trade name
VIEWPOINT(TM) CK SYSTEM
Generic name
Electrosurgical, radio frequency, refractive correction
Applicant
Refractec, Inc.
Date received
2001-03-14
Decision date
2002-04-11
Days to decision
393 days
Decision code
APPR
Product code
MWD
Advisory committee
Ophthalmic
Expedited review
No
Location
Irvine, CA
Statement
APPROVAL FOR THE REFRACTEC VIEWPOINT CK SYSTEM. THIS DEVICE IS INDICATED FOR: TEMPORARY REDUCTION OF SPHERICAL HYPEROPIA IN PATIENTS WHO HAVE 0.75 D TO 3.25 D OF CYCLOPLEGIC SPHERICAL HYPEROPIA, LESS THAN OR EQUAL TO 0.75 D OF REFRACTIVE ASTIGMATISM (MINUS CYLINDER FORMAT), A CYCLOPLEGIC SPHERICAL EQUIVALENT OF 0.75 D TO 3.00 D, AND ARE 40 YEARS OF AGE OR GREATER WITH A DOCUMENTED STABILITY OF REFRACTION FOR THE PRIOR 12 MONTH, AS DEMONSTRATED BY A CHANGE OF LESS THAN 0.50 D IN SPHERICAL AND CYL

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
OPTIPOINT CORNEAL MARKER, MODEL VPT-OPT-450 (K053475)Refractec, Inc.2006-03-03
REFRACTEC MCS-100 (K980522)Refractec, Inc.1998-07-22